Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-05 Sale | 2024-03-05 4:10 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 4,156 | $32.57 | $135,361 | 320,280 (Direct) | View |
| 2024-01-24 Sale | 2024-01-24 4:20 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 7,635 | $21.64 | $165,221 | 151,546 (Direct) | View |
| 2024-01-09 Sale | 2024-01-09 4:28 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 12,066 | $22.99 | $277,397 | 159,181 (Direct) | View |
| 2023-08-08 Sale | 2023-08-10 4:07 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 10,178 | $25.48 | $259,335 | 71,974 (Direct) | View |
| 2023-06-30 Sale | 2023-06-30 4:05 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 11,449 | $28.36 | $324,694 | 158,734 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Exercise | 2024-03-05 4:10 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 8,500 | $0 | 320,280 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 249,500 | $0 | 320,280 (Direct) | View |
| 2024-01-20 Exercise | 2024-01-24 4:20 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 17,018 | $0 | 151,546 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-09 4:28 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 25,527 | $0 | 159,181 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-10 4:07 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 22,691 | $0 | 71,974 (Direct) | View |
| 2023-06-28 Exercise | 2023-06-30 4:05 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 25,528 | $0 | 158,734 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:06 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-09 4:50 pm | N/A 2032-08-08 | AGIOS PHARMACEUTICALS INC. | AGIO | Goff Brian Chief Executive Officer | 629,156 | $0 | 629,156 (Direct) | View |
| 2021-07-21 Disposition | 2021-07-23 4:42 pm | 2018-06-07 2027-06-07 | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 21,750 | $100.14 | 0 (Direct) | View |
| 2021-07-21 Disposition | 2021-07-23 4:42 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 150,832 | $0 | 0 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:43 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 60,144 | $0 | 150,832 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-09 4:52 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,086 | $177 | 90,688 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 5:55 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 24,473 | $0 | 91,774 (Direct) | View |
| 2020-12-16 Tax Withholding | 2020-12-18 5:09 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 21,395 | $157.96 | 67,301 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 5:09 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 40,677 | $0 | 67,301 (Direct) | View |
| 2020-06-08 Tax Withholding | 2020-06-09 4:58 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,642 | $114.61 | 48,019 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-03 6:18 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,401 | $90.54 | 49,661 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 6:18 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 10,880 | $0 | 49,661 (Direct) | View |
| 2020-02-07 Tax Withholding | 2020-02-10 4:58 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,594 | $102.97 | 40,182 (Direct) | View |
| 2019-06-07 Tax Withholding | 2019-06-11 6:38 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,643 | $118.61 | 41,776 (Direct) | View |